共 60 条
- [1] Murad AM(1993)Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37-41
- [2] Santiago FF(2009)Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Lancet Oncol 10 1027-1028
- [3] Petroianu A(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-221
- [4] Rocha PR(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-1820
- [5] Rodrigues MA(2008)Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1 Jpn J Clin Oncol 38 786-789
- [6] Rausch M(2000)Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type Cancer 89 1418-1424
- [7] Boku N(1994)Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer Gan To Kagaku Ryoho 21 1033-1038
- [8] Yamamoto S(1999)A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B) Gan To Kagaku Ryoho 26 487-496
- [9] Fukuda H(2001)Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions Ann Oncol 12 1133-1137
- [10] Shirao K(2002)Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer Gastric Cancer 5 90-95